Bojan Jovic | Medical Director
Allucent
Bojan is an innovative, creative and insightful medical expert with a 17+ years of professional experience and results in the fields of Pharma Industry and Clinical Research. In his current position as Medical Director for Allucent, he is responsible for ensuring the medical/clinical integrity of studies in accordance with the highest ethical and safety standards. Bojan serves as the primary medical contact to investigators and clinical study teams regarding protocol compliance and safety of the subjects enrolled. Prior to this role, Bojan was in various positions in Novartis Medical department, where he worked cross functionally in development of Oncology Clinical Trials program and led a team of people in Oncology and Rare Diseases units. Bojan holds specialisation in Clinical Pharmacology, and a Masters Degree in Physical Activity and Sports Medicine from the University of Belgrade.
Appearances:
Day 2 - Wednesday 29 October @ 11:15
Endpoint Adjudication in Rare Disease Trials: Navigating Uncertainty and Advancing Objectivity in Outcome Assessment
Sources of uncertainty in rare disease endpoints and strategies to address them.
Standardizing endpoint definitions and assessment criteria.
Use of blinded independent adjudication committees.
Practical steps for implementing effective adjudication processes.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events